Prehospital stroke management in the thrombectomy era.


Journal

The Lancet. Neurology
ISSN: 1474-4465
Titre abrégé: Lancet Neurol
Pays: England
ID NLM: 101139309

Informations de publication

Date de publication:
07 2020
Historique:
received: 09 01 2020
revised: 06 03 2020
accepted: 10 03 2020
entrez: 21 6 2020
pubmed: 21 6 2020
medline: 15 9 2020
Statut: ppublish

Résumé

Acute stroke management has been revolutionised by evidence of the effectiveness of thrombectomy. Because time is brain in stroke care, the speed with which a patient with large vessel occlusion is transferred to a thrombectomy-capable centre determines outcome. Therefore, each link in the stroke rescue chain, starting with symptom onset and ending with recanalisation, should be streamlined. However, in contrast to inhospital delays, prehospital delays are unchanged despite substantial efforts in quality improvement. Furthermore, thrombectomy is offered by only a few, usually distant, specialised centres and not by the many other, usually nearer, hospitals. To take maximum advantage of the first so-called golden hours after stroke, and because of the difficulty of on-scene triage decision making with respect to the target hospital offering the required level of care, the focus of stroke research has shifted to the prehospital setting. Current research focuses on the effects of public education, implementation of protocols for emergency medical services for streamlining clinical investigations and accurate triage, use of preclinical scales for stroke recognition, and deployment of novel technical solutions such as smartphone applications, telemedicine, and mobile stroke units.

Identifiants

pubmed: 32562685
pii: S1474-4422(20)30102-2
doi: 10.1016/S1474-4422(20)30102-2
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

601-610

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Klaus Fassbender (K)

Department of Neurology, Saarland University Medical Center, Homburg, Germany. Electronic address: klaus.fassbender@uks.eu.

Silke Walter (S)

Department of Neurology, Saarland University Medical Center, Homburg, Germany.

Iris Q Grunwald (IQ)

School of Medicine, Anglia Ruskin University, Chelmsford, UK; School of Medicine, University of Dundee, Dundee, UK.

Fatma Merzou (F)

Department of Neurology, Saarland University Medical Center, Homburg, Germany.

Shrey Mathur (S)

Department of Neurology, Saarland University Medical Center, Homburg, Germany.

Martin Lesmeister (M)

Department of Neurology, Saarland University Medical Center, Homburg, Germany.

Yang Liu (Y)

Department of Neurology, Saarland University Medical Center, Homburg, Germany.

Thomas Bertsch (T)

Institute of Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Paracelsus Medical University, Nuremberg, Germany.

James C Grotta (JC)

Department of Neurology, Memorial Hermann Hospital, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH